Intolerable pruritis in an HIV-infected man. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Intolerable pruritis in an HIV-infected man. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Clin Care. 1995 Mar;7(3):23, 26. Unique Identifier : AIDSLINE AIDS/95700064
Zuger A


Abstract: Nine out of ten HIV-infected people suffer from dermatologic complaints. Frequently, the morphology of HIV-associated skin lesions is characteristic enough for the clinician to construct an initial diagnosis and initiate a reasonable course of treatment until the diagnosis can be confirmed. However, HIV-associated pruritis can be difficult to diagnose and control. A debilitating itch could indicate eosinophilic, staphylococcal, or idiopathic folliculitis; severe generalisata characteristic of HIV infection; a drug allergy; severe HIV-related dermatophyte infection; or scabies. Scabies, frequently overlooked as a cause of severe pruritis in HIV infection, manifests atypically in HIV-infected individuals. Its spectrum ranges from pruritis with minimal or no cutaneous signs to the widespread, thick, crusted plaques called crusted or Norwegian scabies. Diagnosis requires microscopic inspection of a skin scraping or a biopsy, though response to empiric treatment with antimite agents may also be diagnostic. The frequent need for repeated courses of antimite medication in cases with large mite loads and hyperkeratotic lesions may, however, preclude accurate diagnosis via empiric treatment.
Keywords: Adult Case Report Human HIV Infections/*COMPLICATIONS Insecticides/THERAPEUTIC USE Male Pruritus/*COMPLICATIONS/DRUG THERAPY Pyrethrins/THERAPEUTIC USE Scabies/*COMPLICATIONS/DRUG THERAPY NEWSLETTER ARTICLEKWDadultcasereporthumanhivinfections/KWDcomplicationsinsecticides/therapeuticusemalepruritus/KWDcomplications/drugtherapypyrethrins/therapeuticusescabies/KWDcomplications/drugtherapynewsletterarticle
951030
M95A0963

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .